Biolase Has Received A Notice Of Allowance For Its U.S. Patent Application 17/392,807 Titled "Dual Wavelength Laser Treatment Device"
Portfolio Pulse from Happy Mohamed
Biolase has received a notice of allowance for its U.S. patent application 17/392,807 titled 'Dual Wavelength Laser Treatment Device'. This indicates that the patent office has agreed that the invention is patentable.
September 21, 2023 | 4:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biolase's new patent approval could potentially lead to new product developments and increased market competitiveness.
Patents provide companies with a competitive edge by protecting their inventions from being copied by competitors. This new patent could potentially lead to new product developments, which could increase Biolase's market competitiveness and potentially boost its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100